Ryman Healthcare debt facilities update
NZX RELEASE
10 September 2024
Debt facilities update
Ryman Healthcare (Ryman) has agreed amendments to its debt covenants and extended one
of its banking facilities.
Ryman’s interest coverage ratio (ICR) covenant levels, which apply to both bank facilities
and its institutional term loan (ITL), have been amended for testing periods through to
March 2026 (see table below). The ICR covenant level remains at 2.25x for testing periods
beyond this. There has been no change to the ICR covenant calculation (being adjusted
EBITDA to gross interest expense
1
), Ryman’s other financial covenants or Ryman’s loan
margins.
Chief Financial Officer Rob Woodgate said, “As signaled in our Business Improvement
Performance Update on 2 September 2024, given the continued uncertainty around
residential property market conditions in the near term, we believe a prudent step is to
attain additional covenant headroom for upcoming testing periods. Discussions with our
lenders have been positive and they remain very supportive of Ryman.”
In addition, a $115 million bank facility, previously maturing on 30 September 2024,
has been extended to 1 April 2026.
Ryman’s debt facilities total NZ$3, 018 million which comprises syndicated bank facilities of
NZ$2,598 million
2
, a retail bond of NZ$150 million and an ITL of A$250 million. The
average term to maturity across all facilities is 2. 8 years at 10 September 2024.
Covenant testing period Previous ICR Amended ICR
12 months to 30 September 2024 1.75x 1.50x
12 months to 31 March 2025 1.75x 1.50x
12 months to 30 September 2025 2.00x 1.75x
12 months to 31 March 2026 2.25x 2.00x
ENDS
About Ryman:
Ryman Healthcare was founded in Christchurch in 1984 and owns and operates 49
retirement villages in New Zealand and Australia. Ryman villages are home to 14,600
residents, and the company employs 7,700 staff.
Contacts:
For investor relations information contact Hayden Strickett, Head of Investor Relations, on
027 303 1132 (+64 27 303 1132) or email hayden.strickett@rymanhealthcare.com
For media information or images contact Camille Middleditch on 028 422 3472 or
camille.middleditch@rymanexternal.com
1: See Appendix 11 in Ryman Healthcare’s 2024 result presentation for further detail (link).
2: Includes Australian dollar and multi-currency facilities, both presented in New Zealand
dollars.
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.